Meta Health (SGX:5DX) received a listing and quotation notice from the SGX for listing 23,331,000 consideration shares as part of its acquisition of Jas Medical Screening, a filing with the Singapore Exchange on Wednesday.
The LQN also includes the listing and quotation of 15,554,000 earn-out shares to be issued to Lek. Under the revised terms, earn-out shares will be issued if Jas Medical achieves net profits of at least SG$175,000 in 2025 and 2026, with adjustments linked to changes in Meta's share base.
Meanwhile up to 2,755,400 shares have been allotted as introducer shares.
In an earlier filing, the company had entered into a sale and purchase agreement with Lian Ah Lek to acquire a 55% stake in Jas Medical Screening Centre for SG$533,310.
Of the total consideration, SG$300,000 was payable in cash while 23,331,100 Meta shares were to be allotted and issued to the vendor at an issue price of SG$0.01 apiece, against a 55% stake in the medical screening company.
Shares of the medical services company crashed over 14% in recent trading.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。